The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cunningham, D., Humblet, Y., Siena, S., Khayat, D., Bleiberg, H., Santoro, A., Bets, D., Mueser, M., Harstrick, A., Verslype, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033025 · Cited by 5,035
Kris, M. G., Natale, R. B., Herbst, R. S., Lynch, Jr., Prager, D., Belani, C. P., Schiller, J. H., Kelly, K., Spiridonidis, H., Sandler, A., et al. (2003) · JAMA · doi:10.1001/jama.290.16.2149 · Cited by 2,517
Vogel, C. L., Cobleigh, M. A., Tripathy, D., Gutheil, J. C., Harris, L. N., Fehrenbacher, L., Slamon, D. J., Murphy, M., Novotny, W. F., Burchmore, M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.719 · Cited by 1,860
Saltz, L. B., Meropol, N. J., Loehrer, P. J., Needle, M. N., Kopit, J., & Mayer, R. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.182 · Cited by 1,694
Targeted Disruption of Mouse EGF receptor: Effect of Genetic Background on Mutant Phenotype
Threadgill, D. W., Dlugosz, A. A., Hansen, L. A., Tennenbaum, T., Lichti, U., Yee, D., LaMantia, C., Mourton, T., Herrup, K., Harris, R. C., et al. (1995) · Science · doi:10.1126/science.7618084 · Cited by 1,179
Pérez-Soler, R., Chachoua, A., Hammond, L. A., Rowinsky, E. K., Huberman, M., Karp, D., Rigas, J., Clark, G. M., Santabárbara, P., & Bonomi, P. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.057 · Cited by 1,070
Hidalgo, M., Siu, L. L., Nemunaitis, J., Rizzo, J., Hammond, L. A., Takimoto, C., Eckhardt, S. G., Tolcher, A., Britten, C. D., Denis, L., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.13.3267 · Cited by 1,001
Baselga, J., Rischin, D., Ranson, M., Calvert, H., Raymond, E., Kieback, D. G., Kaye, S. B., Gianni, L., Harris, A., Bjork, T., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.03.100 · Cited by 829
Soulieres, D., Senzer, N. N., Vokes, E. E., Hidalgo, M., Agarwala, S. S., & Siu, L. L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.075 · Cited by 807
Ranson, M., Hammond, L. A., Ferry, D., Kris, M., Tullo, A., Murray, P. I., Miller, V., Averbuch, S., Ochs, J., Morris, C., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.112 · Cited by 763
Baselga, J., Pfister, D., Cooper, M. R., Cohen, R., Burtness, B., Bos, M., D’Andrea, G., Seidman, A., Norton, L., Gunnett, K., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.904 · Cited by 741
Perrotte, P., Matsumoto, T., Inoue, K., Kuniyasu, H., Eve, B. Y., Hicklin, D. J., Radinsky, R., & Dinney, C. P. (1999) · PubMed · Cited by 647
Albanell, J., Rojo, F., Averbuch, S., Feyereislova, A., Mascaro, J. M., Herbst, R. S., LoRusso, P. M., Rischin, D., Sauleda, S., Gee, J., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.110 · Cited by 528
Busam, K. J., Capodieci, P., Motzer, R., Kiehn, T., Phelan, D., & Halpern, A. C. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04226.x · Cited by 419
Rowinsky, E. K., Schwartz, G. H., Gollob, J. A., Thompson, J. A., Vogelzang, N. J., Figlin, R., Bukowski, R., Haas, N., Lockbaum, P., Li, Y.-P., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.061 · Cited by 329
The EGF receptor - an essential regulator of multiple epidermal functions.
Jost, M., Kari, C., & Rodeck, U. (2000) · PubMed · Cited by 302
Mascia, F., Mariani, V., Girolomoni, G., & Pastore, S. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63654-1 · Cited by 276
Vanhoefer, U., Tewes, M., Rojo, F., Dirsch, O., Schleucher, N., Rosen, O., Tillner, J., Kovar, A., Braun, A. H., Trarbach, T., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.114 · Cited by 261
Murillas, R., Larcher, F., Conti, C. J., Santos, M., Ullrich, A., & Jorcano, J. L. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00206.x · Cited by 249
Amador, M. L., Oppenheimer, D., Perea, S., Maitra, A., Cusati, G., Iacobuzio-Donahue, C., Baker, S. D., Ashfaq, R., Takimoto, C., Forastiere, A., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1036 · Cited by 241
Foon, K. A., Yang, X.-D., Weiner, L. M., Belldegrun, A. S., Figlin, R. A., Crawford, J., Rowinsky, E. K., Dutcher, J. P., Vogelzang, N. J., Gollub, J., et al. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.09.098 · Cited by 218
Hansen, L. A., Alexander, N., Hogan, M. E., Sundberg, J. P., Dlugosz, A., Threadgill, D. W., Magnuson, T., & Yuspa, S. H. (1997) · Europe PMC (PubMed Central) · Cited by 209
Plewig, G., & Kligman, A. M. (1992) · Medical Entomology and Zoology · Cited by 202
Practical Management of Patients With Non–Small-Cell Lung Cancer Treated With Gefitinib
Shah, N. T., Kris, M. G., Pao, W., Tyson, L. B., Pizzo, B. M., Heinemann, M.-H., Ben-Porat, L., Sachs, D. L., Heelan, R. T., & Miller, V. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.057 · Cited by 191
Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer
Townsley, C. A., Major, P., Siu, L. L., Dancey, J., Chen, E., Pond, G. R., Nicklee, T., Ho, J., Hedley, D., Tsao, M., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603055 · Cited by 178
Tan, A. R., Yang, X., Hewitt, S. M., Berman, A., Lepper, E. R., Sparreboom, A., Parr, A. L., Figg, W. D., Chow, C., Steinberg, S. M., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.189 · Cited by 176
Can rash associated with HER1/EGFR inhibition be used as a marker of treatment outcome?
Perez-Soler, R. (2003) · PubMed · Cited by 150
Malik, S. N., Siu, L. L., Rowinsky, E. K., deGraffenried, L. A., Hammond, L. A., Rizzo, J. D., Bacus, S. S., Brattain, M. G., Kreisberg, J. I., & Hidalgo, M. M. (2003) · PubMed · Cited by 130
Dermatologic Side Effects Associated with Gefitinib Therapy: Clinical Experience and Management
Herbst, R. S., LoRusso, P. M., Purdom, M., & Ward, D. A. (2003) · Clinical Lung Cancer · doi:10.3816/clc.2003.n.016 · Cited by 119
Pharmacological background of EGFR targeting
Castillo, L., Étienne-Grimaldi, M.-C., Fischel, J., Formento, P., Magné, N., & Milano, G. A. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh257 · Cited by 119
Epidermal Growth Factor Receptor Inhibition Induces Trichomegaly
Dueland, S., Sauer, T., Lund‐Johansen, F., Østenstad, B., & Tveit, K. M. (2003) · Acta Oncologica · doi:10.1080/02841860310006038 · Cited by 108
Mohamed, M. K., Ramalingam, S. S., Lin, Y., Gooding, W. E., & Belani, C. P. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi157 · Cited by 93
Kimyai‐Asadi, A., & Jih, M. H. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.1.129 · Cited by 89
Kiguchi, K., Bol, D. K., Carbajal, S., Beltrán, L., Moats, S., Chan, K. S., Jorcano, J. L., & DiGiovanni, J. (2000) · Oncogene · doi:10.1038/sj.onc.1203778 · Cited by 85
DiGiovanna, J. J. (2001) · Dermatologic Clinics · doi:10.1016/s0733-8635(05)70237-0 · Cited by 62
Weninger, W., Rendl, M., Mildner, M., & Tschachler, E. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00393.x · Cited by 61
Increased Expression of Vascular Endothelial Growth Factor in Pyogenic Granulomas
Bragado, R., Bello, E., Requena, L., Renedo, G., Texeiro, E., Alvarez, M., Castilla, M. Á., & Caramelo, C. A. (1999) · Acta Dermato Venereologica · doi:10.1080/000155599750009834 · Cited by 58
Wakita, H., & Takigawa, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37285 · Cited by 57
Mimeault, M., Bonenfant, D., & Batra, S. K. (2004) · Skin Pharmacology and Physiology · doi:10.1159/000078818 · Cited by 36
Xie, W., Wu, X., Chow, L. T., Chin, E., Paterson, A. J., & Kudlow, J. E. (1998) · PubMed · Cited by 35
Lung cancer prevention: retinoids and the epidermal growth factor receptor-a phoenix rising?
Averbuch, S. D. (2002) · PubMed · Cited by 28
Gobel, B. H. (2004) · Clinical journal of oncology nursing · doi:10.1188/04.cjon.316-320 · Cited by 11
Cited by
Mechanisms of cutaneous toxicities to EGFR inhibitors
Lacouture, M. E. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1970 · Cited by 789
Thatcher, N., Hirsch, F. R., Luft, A. V., Szczesna, A., Ciuleanu, T. E., Dediu, M., Ramlau, R., Galiulin, R. K., Bálint, B., Losonczy, G., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00021-2 · Cited by 479
Lacouture, M. E., Anadkat, M. J., Bensadoun, R.-J., Bryce, J., Chan, A., Epstein, J. B., Eaby-Sandy, B., Murphy, B. A., & MASCC Skin Toxicity Study Group (2011) · Supportive Care in Cancer · doi:10.1007/s00520-011-1197-6 · Cited by 444
Wacker, B., Nagrani, T., Weinberg, J., Witt, K., Clark, G., & Cagnoni, P. J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2610 · Cited by 384
Lynch, T. J., Kim, E. S., Eaby, B., Garey, J., West, D. P., & Lacouture, M. E. (2007) · The Oncologist · doi:10.1634/theoncologist.12-5-610 · Cited by 341
Metadata
- Authors
- Segaert, S., & Van Cutsem, E.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2005-09
- Volume
- 16
- Issue
- 9
- Pages
- 1425-1433
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2163592822
- Cited by
- 571
- References
- 42
- FWCI
- 42.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.